This industry requires a specialist who deals
with pharmaceutical business insurance on a regular basis.
Not exact matches
MONTREAL — Valeant
Pharmaceuticals faces years of legal challenges despite cutting ties
with a U.S. mail - order pharmacy at the centre of a controversy about how Canada's largest publicly traded drug firm conducts its
business, say industry observers and the company's second - largest shareholder.
Trujillo juggles a full - time job as a communications manager at a
pharmaceuticals company
with managing the
business.
Ackman's Pershing Square Capital teamed up
with Valeant to mount a failed hostile takeover of rival
pharmaceutical company Allergan, and at the time, the famed fund manager credited Pearson for being able to spot opportunities where others couldn't, much like
business legend Warren Buffett.
Fortune spoke
with 25 - year
pharmaceutical vet Ramona Sequeira, president of Takeda's U.S.
business unit since 2015, on the challenges of adapting an international pharma company to the U.S. healthcare and reimbursement system and the firm's America - centric
business plans.
Takeda's negotiations to acquire Valeant
Pharmaceuticals International's Salix stomach - drug
business have stalled over price disagreements, Reuters reported in November, citing people familiar
with the matter.
In addition, CMMB's volunteer program provides medical and
business know - how for community development and engages
with the
pharmaceutical industry to help meet the needs of the poor around the world.
More recently, it's struggled to strike a deal for its consumer healthcare
business,
with major potential bidders like GlaxoSmithKline pulling out and Procter & Gamble deciding to buy German
pharmaceutical company Merck KGaA's consumer unit instead.
Adding Actelion's portfolio to our already strong Janssen
Pharmaceuticals business is a unique opportunity for us to expand our portfolio
with leading, differentiated in - market medicines and promising late - stage products.
Discussing President - elect Trump's comments on the
pharmaceutical industry
with Bill George, Harvard
Business School senior fellow and former Medtronic CEO.
We may face increasing competition for additional new product acquisitions from
pharmaceutical companies as new companies emerge
with a similar
business model and other more established companies focus on acquiring products to develop their pipeline.
Interviews
with former Sprout employees, analysts, investors and doctors who helped bring the drug to market suggest how a series of missteps after the deal, along
with turbulence from aggressive accounting practices, unusual
business relationships and big egos, derailed one of the most intriguing new
pharmaceuticals in a generation.
Mr. Jiwan has served on numerous boards of directors and advisors, including: (i) Future Finance Loan Corporation, a European private student lender that has helped students at over 130 universities fund their education, where Mr. Jiwan is a co-founder and non-executive Chairman; (ii) BFRE, a Brazilian private real estate finance company, which was subsequently sold to affiliates of BTG Pactual; (iii) GP Investimentos, one of Latin America's leading private equity firms, where he served on its shareholder advisory board; (iv) NewPoint Re, a Bermuda - based reinsurance
business; and (v) Kaletra QD product development program
with Abbott
Pharmaceuticals, where he served on the Joint Oversight Committee.
With almost 200 stocks in its portfolio, the iShares ETF claims about 80 % of its assets are invested in biotechnology specifically, with the remaining 20 % split between pharmaceutical companies and businesses specializing in tools and services for the life sciences indus
With almost 200 stocks in its portfolio, the iShares ETF claims about 80 % of its assets are invested in biotechnology specifically,
with the remaining 20 % split between pharmaceutical companies and businesses specializing in tools and services for the life sciences indus
with the remaining 20 % split between
pharmaceutical companies and
businesses specializing in tools and services for the life sciences industry.
Paragon, diode by former Miss Iowa Jessica Versteeg, is trying to standardize associate degreed regulate the cannabis
business through the ability of a changeless ledger on blockchain technology to assist the polemical plant to contend
with the massive
pharmaceutical company.
About DuPont Nutrition & Health DuPont Nutrition & Health, a
business unit of DowDuPont Specialty Products Division, combines in - depth knowledge of food and nutrition
with current research and expert science to deliver unmatched value to the food, beverage,
pharmaceutical and dietary supplement industries.
DuPont Nutrition & Health, a
business unit of DowDuPont Specialty Products Division, combines in - depth knowledge of food and nutrition
with current research and expert science to deliver unmatched value to the food, beverage,
pharmaceutical and dietary supplement industries.
Through its Nutrition & Health
business, a
business unit of DowDuPont Specialty Products Division, DuPont combines in - depth knowledge of food and nutrition
with current research and expert science to deliver unmatched value to the food, beverage,
pharmaceutical and dietary supplement industries.
Working
with companies in the areas of finance, insurance,
pharmaceutical, IT, sports and gaming, entertainment, and renewable energies, we serve as outside legal counsel for all
business needs.
If we're going to be the very best at the things we are good at - advanced manufacturing, creative industries,
business services,
pharmaceuticals, renewables - then government has to work in partnership
with business.
Many
pharmaceutical and biotech companies work
with freelancers — independent
business owners who contract directly
with companies — but the staffing agency model is much more common, especially among less experienced workers.
Our executive and scientific search practice operates
with two parallel
business tracks:
pharmaceutical sciences and agricultural sciences.
Pissarra's own
business idea came from his conversations
with Portuguese
pharmaceutical scientists.
My scientific background gave me the tools I needed to manage the challenges of the
business environment in the
pharmaceutical industry, such as working in cross-functional teams
with varied objectives and agendas.
She is CEO of PsychoGenics Inc., a profitable preclinical CNS service company, CEO of PGI Drug Discovery LLC, a company engaged in psychiatric drug discovery
with three partnered Phase II clinical programs and Adjunct Associate Professor of Neuroscience at Mount Sinai School of Medicine, Dr. Leahy has more than 25 years of experience in drug discovery, clinical develop and
business development for
pharmaceutical and biotechnology companies, including extensive knowledge of technology assessment, licensing, mergers and acquisitions, and strategic planning.
In addition to conducting and funding research to develop more effective and safer therapies, NCI has thriving research programs in critically important areas like survivorship, delivery of care, primary prevention, screening, and quality of life — areas that are not traditionally supported by the private sector because they have limited commercial value or are not a good fit
with traditional
pharmaceutical and biotech
business models.
Prior to joining Qurr, Dr. Padliya worked closely
with the North American salesforce at AB SCIEX to perform several winning demonstrations of accurate high - resolution mass spectrometers that paved the way for new
business opportunities
with major
pharmaceutical and biotechnology accounts.
At last count, over 11,000
businesses were engaging in the Internet sales of
pharmaceuticals,
with only an average of 4 % of them in accord
with proper medicinal dispensing guidelines.
Mr. Reeb is a
business consultant and strategic executive
with over 30 years of leadership experience
with dynamic, high - growth organizations including Allergan
Pharmaceuticals, AmeriCredit Corporation, Aramark Corporation, GlaxoSmithKline PLC, Smith International, Verizon Communications and Vodafone Group.
Johnson and Johnson is firing on all cylinders, and I love its two - pronged
business model of well - known consumer healthcare and personal - care products combined
with branded
pharmaceuticals.
Investing in the health - care sectorA dynamic sector: From biotech to
pharmaceuticals, the fund seeks out companies that profit from the global demand for health care.A range of companies: The fund invests worldwide in
businesses at different stages of growth, from rapidly growing newer companies to established global corporations.Actively managed: Unlike passively managed ETFs, Putnam global sector funds combine rigorous fundamental research and disciplined quantitative analysis
with macroeconomic views.
During her twelve years
with the firm, she advised
pharmaceutical, biotechnology, and medical device clients on successful product development,
business development, and marketing strategies.
Michael O'Bryan is the Executive Vice President of
Business Operations for the Virbac Corporation, a leading companion animal health company
with products in the
pharmaceutical, dermatological and oral hygiene markets for pets based in Fort Worth, Texas.Prior to joining Virbac, O'Bryan managed the marketing and sales departments at Purina.
Urbanek has broad experience in
pharmaceutical manufacturing, in both drug product and bulk manufacturing, as well as working closely
with the Lilly
business units.
And a newspaper talking about trouble
with pharmaceuticals and a guy taking care of
business is unannounced?
We have neutrals
with extensive experience in virtually every practice area, including antitrust, banking, civil rights, consumer actions, employment, environmental / toxic tort, healthcare, insurance coverage, intellectual property, product liability / torts,
pharmaceutical / medical devices, securities, and unfair
business practices.
«The most successful law firms are the ones who just get on
with it — they stop talking about it and actually start experimenting — very much in the R&D spirit of consumer electronics and
pharmaceutical industry where these
businesses don't know where their income is coming from in five years time so they engage in R&D.
The big
pharmaceutical company, Johnson & Johnson, was found liable for design flaws, manufacturing defects, fraud, deceptive
business practices, and the claim also asserts that the company acted
with wanton, reckless, or malicious conduct.
Notable mandates: The firm represented Mallinckrodt
Pharmaceuticals in connection
with a global corporate reorganization of its contrast media and delivery system
business and in connection
with the US$ 270 - million sale of that
business to Paris - based Guerbet.
Mr. Pletcher is an experienced trial lawyer
with a focus on cases involving commercial
business disputes, products liability, professional negligence, and employment, health care,
pharmaceutical, medical device and biotech litigation and civil appeals.
We acted, in conjunction
with several international law firms, including our tie - up office, Addleshaw Goddard LLP, as a legal advisor for a UK - based, London Stock Exchange (AIM) listed company that is engaged worldwide in the
business of
pharmaceuticals in a transaction that could be worth as much as £ 100 million, where this company sought to acquire 100 % ownership of a globally oriented Singaporean company engaged in the distribution of highly specialized
pharmaceutical and medical technology in Asia, Africa and Australia.
Mr. Lynch has assisted
with deals involving
businesses across various industries, such as food and beverages, commercial explosives, waste hauling,
pharmaceuticals, manufacturing, aerospace, and defense.
Before joining Arent Fox in 2004, Ricardo was a partner in a major law firm in the city of Caracas, Venezuela where he represented various
pharmaceutical, food, and entertainment companies doing
business in Venezuela and South America in areas including foreign investment requirements and compliance, regulatory compliance
with focus on food and
pharmaceuticals, and intellectual property — namely trademark protection and litigation, data access, and privacy and patent litigation (mostly design patent).
An IP lawyer
with keen
business savvy, Dr. Jarrell's extensive technical credentials make her well versed in a wide variety of technologies in the biotech,
pharmaceutical, and specialty chemical industries.
In question 25, respondents said one of the top things a firm can do to improve working relationships
with their company was be more proactive, and in a highly regulated industry such as
pharmaceuticals, Cullen appreciates a heads up to regulatory changes or new legislation that might impact his
business.
That has meant building strong relationships
with leaders in the private and public healthcare sectors, as well as advising a range of clients from hospitals and clinics to
pharmaceutical manufacturers and suppliers on the corporate, commercial and regulatory aspects of doing
business in the UAE.
He started his career as a
business analyst
with a
pharmaceutical Company.
The rumor that Amazon has set its sights on disrupting the
pharmaceutical industry has gained greater currency recently, just months after the company set the grocery
business on fire
with its acquisition of Whole Foods, and in the midst of its widely publicized search for a second U.S. headquarters location.
Six chapters
with simple, tried - and - true explanations of mathematical concepts,
pharmaceutical systems of measurement, dosage calculations, concentrations, and pharmacy
business calculations.
Hays Commercial Operations experts work
with a number a multitude of Biotech's, CRO's,
Pharmaceuticals and Strategic Consulting firms, while the jobs we offer to our candidates include both those at more junior levels such as Therapy Area Specialists jobs or
Business Intelligence Analysts jobs, as well as Marketing / Brand Directors jobs or Principal Consultants jobs.